Board Members

Julianne M. Bowler joined RTI’s Board of Directors in May 2007. Bowler is the Chief Compliance and Administrative Officer for Narragansett Bay Insurance Company, a position she has held since May 2009. Prior to that position, she was an insurance consultant working with various companies and organizations such as Bearing Point, Commercial Union/OneBeacon and Geico. she served as commissioner of insurance for the Massachusetts Division of Insurance, based in Boston, Mass., from March 2002 to January 2007. She has more than 10 years of experience in insurance regulation and health policy for companies such as Blue Cross Blue Shield of Massachusetts and the University of Massachusetts Medical Center, including nine years with the Massachusetts Division of Insurance. Bowler has a bachelor’s degree in philosophy from Assumption College in Worcester, Mass., and a master’s degree in philosophy from the University of Dallas in Dallas, Tex. She was a doctoral candidate in biomedical ethics at Georgetown University in Washington, D.C., and received her master’s degree in business administration with a concentration in finance from the University of Massachusetts in Boston, Mass.

Philip R. Chapman has served as a member of RTI’s Board of Directors since February 1998. He is the president of Venad Administrative Services, Inc. and has been a general partner of Adler & Company since 1995. From 1991 until 1995, he served as a principal of Adler & Company. From 1981 until 1989, Chapman served as a senior consultant at Booz Allen & Hamilton International. Chapman is also a director of Shells Seafood Restaurants, Inc. He holds a bachelor’s degree and masters of business administration degree from Columbia University.

Roy D. Crowninshield, Ph.D. served as the Interim Chief Executive Officer of Tutogen Medical, Inc. from July 2004 to December 2004. Prior to joining Tutogen, Dr. Crowninshield served 21 years in various capacities at Zimmer Holdings, Inc., including President of Zimmer’s U.S. operations and most recently as the Company’s Chief Scientific Officer. Prior to joining Zimmer, Inc. in 1983, he was a faculty member at the University of Iowa where he led many research projects evaluating the function of total joint implants. He currently holds academic appointments as a professor in the Orthopedic Surgery Department at Rush Medical College in Chicago, Illinois and as an adjunct professor in the College of Engineering of the University of Notre Dame. He holds undergraduate and doctorate degrees from the University of Vermont. He has worked in the orthopedic industry for more than 20 years and has extensive experience in the research and development, manufacture, and clinical investigation of orthopedic implants. He has authored more than 100 journal articles, book chapters, and published abstracts in orthopedics and engineering.

Peter F. Gearen, M.D. has served as a member of RTI’s Board of Directors since February 1998. Dr. Gearen was chief of staff at Shands Hospital at the University of Florida and served as assistant dean of clinical affairs at the University of Florida College of Medicine from 1992 until 1999. He has been an associate professor at the University of Florida College of Medicine since 1993. Dr. Gearen is also a director of Motion Engineering, Inc. He holds a bachelor’s degree from Spring Hill College and received his M.D. from Stritch Loyola Medical School.

Brian Hutchison was named chief executive officer for RTI Biologics in February 2008. He joined RTI in December 2001 as president and CEO and served as chairman of the board of directors from December 2002 to May 2011.

In his role at RTI, Hutchison oversees all aspects of the company and its affiliates. Hutchison spent the previous 12 years with Stryker Corporation, based in Kalamazoo, Mich. He served most recently as vice president, worldwide product development and distribution.

A native of Muskegon, Mich., Hutchison earned a bachelor’s degree in business administration from Grand Valley State University in 1981. He also completed the Program for Management Development from Harvard Business School in 1995.

Gregory P. Rainey joined RTI’s Board of Directors in March 2007. He is also currently serving on the boards for CAS Medical Systems, Inc. and NuOrtho Surgical, Inc. He is the president of CCI Performance Group, a sales and marketing consultant company. Prior to opening CCI Performance Group in 2004, Rainey served 10 years with Stryker Corporation, most recently as vice president of sales for Stryker’s Orthopedics Division for four years. Previous to Stryker, Rainey served as director of sales for Joint Medical Corporation, as well as sales positions with U.S. Surgical Corporation. He earned a bachelor’s degree in biology from Loyola University.

Adrian J.R. Smith has been the Chief Executive Officer of The Woolton Group since 1997. He is also the Non-Executive Chairman of Gaming VC S.A., and a Non-Executive Director of Byotrol plc. His business career includes 13 years in the professional services industry and 24 years with two Fortune 500 companies. He has been a Global Managing Partner, Marketing & Communication at Deloitte Touche Tohmatsu, the Chief Executive Officer of Grant Thornton LLP, and a Managing Partner at Arthur Andersen in the early to mid-1990’s. He held senior international management roles with Ecolab Inc. and also with Procter & Gamble. He serves on the board of the Education Foundation of Indian River County in Florida.